DMD develops therapeutics targeting muscle tissue through strategic collaborations involving Roche, Recursion, and Dyne Therapeutics.
1 report, 1 independent
Updated Jul 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
DMD develops therapeutics targeting muscle tissue through strategic collaborations involving Roche, Recursion, and Dyne Therapeutics.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
DMD
Nothing else this week.
-
Hoffmann-La Roche
Swiss healthcare company
-
Recursion (United States)
company in Salt Lake City, United States